GRI BioGRI

GRI Bio Inc is a clinical-stage biotech company focused on discovering, developing, and commercializing therapies targeting serious diseases associated with dysregulated immune responses that to inflammatory, fibrotic, and autoimmune disorders.

Ratings

0 / 5

0 ratings in the last 12 months

5
4
3
2
1
CEO
Dr. W. Marc Hertz, PhD

$757.5K

Market Cap • 27/03/2024

2009

(há 15 anos)
Fundação

2023

(1 year ago)
IPO

NASDAQ

Listagem
Flag of US

La Jolla

Sede • California

Valuation

Valuation Indicators

Retorno Histórico

GRISó no Premium...

Visualize o retorno de longo prazo das ações. Dividendos e outros eventos são considerados.

0%

1 dia

25/03/2024

-3%

1 semana

20/03/2024

-4%

1 mês

27/02/2024

-99%

1 ano

27/03/2023

10 anos

Histórico